LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver rarely shouts in the beginning. It whispers.Liver Function Tests, or LFTs, ...

Juxtapid has been available to treat adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high levels of LDL cholesterol.

Losing a battle you cannot see is one of the biggest challenges in medicine. And for many Americans, that quiet fight happens ...

A woman whose son was stillborn has said her severe symptoms were dismissed as “nothing to worry about” by NHS hospital staff but she “still feels like a mother despite it all”. Natasha Anderson, 34, ...

Natasha Anderson and Nicholas Harewood discovered they were expecting a baby in June 2025 and were ‘over the moon’.

Topline data of investigator‑initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% ...

Namodenoson (CF102) demonstrated a favorable safety profile in patients with advanced pancreatic ductal adenocarcinoma (PDAC) in a phase 2a clinical study, meeting the trial’s primary end point and ...

Topline data of investigator-initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% complete response ...

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...